Clinical and pathological aspects of toxic myopathies
- PMID: 38907023
- DOI: 10.1007/s00415-024-12522-x
Clinical and pathological aspects of toxic myopathies
Abstract
As the most frequent cause of acquired myopathy, toxic myopathies are characterised by clinicopathological features that vary depending on the mode of action of the drugs or toxins involved. Although a large number of substances can induce myotoxicity, the main culprits are statins, alcohol, and corticosteroids. A rigorous, well-organised diagnostic approach is necessary to obtain a rapid diagnosis. For early diagnosis and management, it is important for clinicians to be aware that most toxic myopathies are potentially reversible, and the goal of treatment should be to avoid serious muscle damage.
Keywords: Corticosteroids; Muscle biopsy; Myopathy; Statin; Toxic.
© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Peters SA, Kley RA (2019) Toxic and drug-induced myopathies. Clinical scenario and imaging. In: Barkhof F, Jäger HR, Thurnher MM, Rovira A (eds) Clinical neuroradiology - the ESNR textbook. Springer Nature
-
- Khefli A, Azzouz M, Abtroun R et al (2016) Myopathies toxiques: vue d’ensemble. Toxicol Analyt Clin 28:187–199
-
- Doughty CT, Amato AA (2019) Toxic myopathies. Continuum (Minneap Minn) 25:1712–1731 - PubMed
-
- Khefli A, Azzouz M, Abtroun R et al (2017) Exploration des myopathies toxiques: de l’anamnèse aux méthodes de pharmacogénomique. Toxicol Analyt Clin 29:273–297
-
- Wattjes MP, Fisher DS (2013) Neuromuscular imaging. Springer, New York
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
